Cancer Diagnostics Market Size, Share & Trends Report

Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-213-6
  • Number of Pages: 240
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Cancer Diagnostics Product Outlook (Revenue, USD Billion, 2018 - 2030)
    • Instruments
      • Pathology-based Instruments
        • Slide Staining Systems
        • Tissue Processing Systems
        • Cell Processors
        • PCR Instruments
        • NGS Instruments
        • Microarrays
        • Other Pathology-based Instruments
      • Imaging Instruments
      • Others
    • Consumables
      • Antibodies
      • Kits & reagents
      • Probes
      • Others
    • Services
  • Cancer Diagnostics Type Outlook (Revenue, USD Billion, 2018 - 2030)
    • IVD
      • By Type
        • Diagnosis
        • Early Detection
        • Therapy Selection
        • Monitoring
      • By Technology
        • Polymerase Chain Reaction (PCR)
        • In Situ Hybridization (ISH)
        • Immunohistochemistry (IHC)
        • Next-generation Sequencing (NGS)
        • Microarrays
        • Flow Cytometry
        • Immunoassays
        • Other IVD Testing Technologies
    • LDT
    • Imaging
      • Magnetic Resonance Imaging (MRI)
      • Computed Tomography (CT)
      • Positron Emission Tomography (PET)
      • Mammography
      • Ultrasound
      • Others
  • Cancer Diagnostics Application Outlook (Revenue, USD Billion, 2018 - 2030)
    • Breast Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Blood Cancer
    • Kidney Cancer
    • Liver Cancer
    • Pancreatic Cancer
    • Ovarian Cancer
    • Others
  • Cancer Diagnostics End-use Outlook (Revenue, USD Billion, 2018 - 2030)
    • Hospitals
    • Laboratories
    • Others
  • Cancer Diagnostics Test Type Outlook (Revenue, USD Billion, 2018 - 2030)
    • Biopsy
      • Fine-needle Aspiration
      • Core Biopsy
      • Surgical Biopsy
      • Skin Biopsy /Punch Biopsy
      • Others
    • Others
  • Cancer Diagnostics Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • North America Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • North America Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • North America Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • North America Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • North America Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • U.S.
        • U.S. Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • U.S. Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • U.S. Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • U.S. Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • U.S. Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Canada
        • Canada Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Canada Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Canada Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Canada Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Canada Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
    • Europe
      • Europe Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Europe Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Europe Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Europe Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Europe Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Germany
        • Germany Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Germany Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Germany Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Germany Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Germany Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • UK
        • UK Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • UK Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • UK Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • UK Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • UK Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • France
        • France Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • France Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • France Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • France Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • France Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Italy
        • Italy Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Italy Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Italy Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Italy Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Italy Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Spain
        • Spain Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Spain Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Spain Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Spain Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Spain Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Denmark
        • Denmark Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Denmark Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Denmark Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Denmark Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Denmark Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Sweden
        • Sweden Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Sweden Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Sweden Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Sweden Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Sweden Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Norway
        • Norway Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Norway Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Norway Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Norway Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Norway Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
    • Asia Pacific
      • Asia Pacific Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Asia Pacific Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Asia Pacific Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Asia Pacific Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Asia Pacific Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • China
        • China Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • China Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • China Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • China Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • China Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Japan
        • Japan Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Japan Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Japan Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Japan Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Japan Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • India
        • India Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • India Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • India Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • India Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • India Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Thailand
        • Thailand Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Thailand Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Thailand Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Thailand Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Thailand Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • South Korea
        • South Korea Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • South Korea Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • South Korea Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • South Korea Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • South Korea Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Australia
        • Australia Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Australia Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Australia Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Australia Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Australia Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
    • Latin America
      • Latin America Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Canada Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Latin America Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Latin America Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Latin America Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • Brazil
        • Brazil Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Brazil Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Brazil Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Brazil Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Brazil Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Mexico
        • Mexico Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Mexico Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Mexico Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Mexico Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Mexico Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Argentina
        • Argentina Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Argentina Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Argentina Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Argentina Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Argentina Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
    • Middle East and Africa (MEA)
      • Middle East and Africa (MEA) Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
        • Instruments
          • Pathology-based Instruments
            • Slide Staining Systems
            • Tissue Processing Systems
            • Cell Processors
            • PCR Instruments
            • NGS Instruments
            • Microarrays
            • Other Pathology-based Instruments
          • Imaging Instruments
          • Others
        • Consumables
          • Antibodies
          • Kits & reagents
          • Probes
          • Others
        • Services
      • Middle East and Africa (MEA) Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
        • IVD
          • By Type
            • Diagnosis
            • Early Detection
            • Therapy Selection
            • Monitoring
          • By Technology
            • Polymerase Chain Reaction (PCR)
            • In Situ Hybridization (ISH)
            • Immunohistochemistry (IHC)
            • Next-generation Sequencing (NGS)
            • Microarrays
            • Flow Cytometry
            • Immunoassays
            • Other IVD Testing Technologies
        • LDT
        • Imaging
          • Magnetic Resonance Imaging (MRI)
          • Computed Tomography (CT)
          • Positron Emission Tomography (PET)
          • Mammography
          • Ultrasound
          • Others
      • Middle East and Africa (MEA) Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Lung Cancer
        • Prostate Cancer
        • Skin Cancer
        • Blood Cancer
        • Kidney Cancer
        • Liver Cancer
        • Pancreatic Cancer
        • Ovarian Cancer
        • Others
      • Middle East and Africa (MEA) Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
        • Hospitals
        • Laboratories
        • Others
      • Middle East and Africa (MEA) Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
        • Biopsy
          • Fine-needle Aspiration
          • Core Biopsy
          • Surgical Biopsy
          • Skin Biopsy /Punch Biopsy
          • Others
        • Others
      • South Africa
        • South Africa Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • South Africa Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • South Africa Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • South Africa Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • South Africa Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Saudi Arabia
        • Saudi Arabia Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Saudi Arabia Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Saudi Arabia Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Saudi Arabia Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Saudi Arabia Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • UAE
        • UAE Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • UAE Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • UAE Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • UAE Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • UAE Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others
      • Kuwait
        • Kuwait Cancer Diagnostics Market, By Product 2018- 2030 (USD Billion)
          • Instruments
            • Pathology-based Instruments
              • Slide Staining Systems
              • Tissue Processing Systems
              • Cell Processors
              • PCR Instruments
              • NGS Instruments
              • Microarrays
              • Other Pathology-based Instruments
            • Imaging Instruments
            • Others
          • Consumables
            • Antibodies
            • Kits & reagents
            • Probes
            • Others
          • Services
        • Kuwait Cancer Diagnostics Market, By Type 2018- 2030 (USD Billion)
          • IVD
            • By Type
              • Diagnosis
              • Early Detection
              • Therapy Selection
              • Monitoring
            • By Technology
              • Polymerase Chain Reaction (PCR)
              • In Situ Hybridization (ISH)
              • Immunohistochemistry (IHC)
              • Next-generation Sequencing (NGS)
              • Microarrays
              • Flow Cytometry
              • Immunoassays
              • Other IVD Testing Technologies
          • LDT
          • Imaging
            • Magnetic Resonance Imaging (MRI)
            • Computed Tomography (CT)
            • Positron Emission Tomography (PET)
            • Mammography
            • Ultrasound
            • Others
        • Kuwait Cancer Diagnostics Market, by Application 2018- 2030 (USD Billion)
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Lung Cancer
          • Prostate Cancer
          • Skin Cancer
          • Blood Cancer
          • Kidney Cancer
          • Liver Cancer
          • Pancreatic Cancer
          • Ovarian Cancer
          • Others
        • Kuwait Cancer Diagnostics Market, by End-use 2018- 2030 (USD Billion)
          • Hospitals
          • Laboratories
          • Others
        • Kuwait Cancer Diagnostics Market, by Test Type 2018- 2030 (USD Billion)
          • Biopsy
            • Fine-needle Aspiration
            • Core Biopsy
            • Surgical Biopsy
            • Skin Biopsy /Punch Biopsy
            • Others
          • Others

Cancer Diagnostics Market Dynamics

Drivers: Rising Prevalence Of Cancer

Global rise in the prevalence of cancer is one of the major factors facilitating market growth in the recent past. For instance, according to PAHO, an estimated 20 million new cancer cases and 10 million deaths are expected in 2023, and the annual reported cases of cancer are expected to reach about 30 million by 2040. The need to develop diagnostic options that can detect cancer at an early stage, which can help improve disease management & reduce mortality, is likely to propel the overall market growth. It is also indicated that one in six women and one in five men are likely to develop cancer at some point in their lives. In addition, the 5-year prevalence was around 50.5 million in 2020. The rise in the number of cancer cases can be majorly attributed to various factors such as the rising geriatric population, increasing population, and changing prevalence of certain causes of cancer associated with economic & social development.

Technological Advancements

The demand for cancer diagnosis tools is significantly increasing worldwide due to technological advancements in the field of cancer diagnosis. FDA support for developing cancer biomarkers & mass cytometry; launch of various flow cytometry reagents for drug discovery & diagnosis; technologically advanced miniaturized devices, facilitating portability & precision; development of cell- & bead-based flow cytometry techniques is boosting the market growth. Moreover, increasing initiatives to develop novel imaging solutions to diagnose cancer more accurately are expected to fuel the market growth over the forecast period. The rising use of microfluidic technology for cancer diagnosis is another major factor responsible for replacing conventional methods of diagnosis. Similarly, the use of AI is significantly increasing in the cancer diagnosis industry. AI tools are used for the identification of suspicious areas seen during an MRI scan, which requires biopsies to confirm the presence of malignant cells. Thus, the advent of such technological advancements is propelling market growth.

Restraints: High Cost Of Diagnostic Imaging

Diagnostic cancer tests are expensive, increasing the financial burden on families of patients. The government insurance framework is not as well-defined in developing countries as they are in developed countries. Thus, the middle-class patient population who are not covered under any insurance (private or government) cannot afford these tests. In addition, many private insurance players do not cover costs associated with cancer diagnosis in developing countries. As a result, the high cost of diagnosis is limiting the adoption of cancer screening tools, especially in developing countries. However, the scenario is expected to change in the coming years owing to booming medical tourism in countries such as India and Malaysia, wherein healthcare treatments & diagnostic solutions are becoming affordable. The cost of imaging tests for cancer diagnosis has significantly increased, as these tests are used to confirm cancers and for the prognosis of diseases during the treatment. For instance, the total out-of-pocket cost for all diagnostic tests for breast cancer in the U.S. is more than USD 6,000.

What Does This Report Include?

This section will provide insights into the contents included in this cancer diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Cancer diagnostics market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Cancer diagnostics market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon